Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2026-04-16 17:03:36 ET · period of report 2026-04-15 · accession 0001193125-26-159276 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-16 17:03 | 2026-04-15 | KMTS | Webster Brian Daniel | See Remarks, Dir | S - Sale | $20.04 | -15.0K | 349.8K | -4% | -$300.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-04-15 | S | D | 15,000 | $20.04 | 349,786 | D | — | — | (F1) The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. (F2) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.2200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |